Close Menu

Moody's

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday. The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it is buying One Lambda for $925 million, ratings agency Moody's Investors Service downgraded the company's s

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Moody's Investors Service has upgraded $2.3 billion of Life Technologies' Senior Unsecured Notes to investment grade from speculative grade.

Earlier this month the California Institute for Regenerative Medicine said it plans to privately sell $200 million in bonds in this and the following fiscal year in case it will be unable to access public capital.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.